Regulatorische Updates

The Korean Pharmacists' Association staged its 357th consecutive relay protest in front of the Blue House, urging the government and National Assembly to clarify licensing scopes and resolve role conflicts between pharmacists and han‑yak (traditional medicine) pharmacists.

The first regular Health and Welfare Committee meeting showed sharp partisan clashes, focusing on the MFDS’s responsibility linked to the Justice Minister nominee.

South Korea's MFDS has detailed new review criteria and updated guidelines for digital therapeutic device trials covering seven mental‑health and substance‑use disorders.

The Korean Pharmacy Association for Health Society urges a shift to a public, non‑profit telemedicine platform ahead of the December 24 medical law amendment.

Pharmacists have staged a 356‑day relay rally outside the Blue House, urging resolution of confusion surrounding han‑yak‑sa licensing and a safe drug environment.

The Korean Pharmacists Association marked the 355th consecutive day of a relay rally in front of the Blue House, urging the government to address licensing issues affecting herbal medicine pharmacists.

The KPA’s Emergency Committee held its first operating and execution meetings to plan actions against the government’s push to broaden prescription drug delivery for telemedicine.

Lawmakers begin a series of government‑question sessions, with pharmacist concerns under watch as the agenda runs through Aug 14.

The Korean Pharmaceutical Association has launched an emergency committee and announced protests on March 13 and 20 to oppose the government's plan to broaden delivery of prescription drugs for telemedicine.

A bill was filed on the 9th to add reciprocity rules to South Korea's national pension system, aiming to curb foreign nationals' misuse of post‑payment contributions.

The Korean Pharmaceutical Association launched an emergency response committee to oppose the government's plan to expand prescription drug delivery for telemedicine, announcing coordinated action across regional branches.

Veteran pharmacist Jin Gyo‑seong urges Korean pharmacists to unite under the KPA and focus on government response to telemedicine prescription delivery and safety‑stock drug expansion.